/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Ani Nalbandian

Columbia University Irving Medical Center(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

14

Papers

5.5K

Citations

7

h-index

7

i10-index

Ani Nalbandian is an academic researcher from Columbia University Irving Medical Center. The author has contributed to research in topics: Parathyroid Disorders and Treatments & Amyloidosis: Diagnosis, Treatment, Outcomes & COVID-19 Clinical Research Studies. The author has an h-index of 7, co-authored 12 publications.

ORCID: 0000-0002-5615-7328

Research Topics

Parathyroid Disorders and Treatments Amyloidosis: Diagnosis, Treatment, Outcomes COVID-19 Clinical Research Studies Long-Term Effects of COVID-19 SARS-CoV-2 and COVID-19 Research

Papers by this author

works

Post-acute COVID-19 syndrome

2021 · Nature Medicine · 4,912 citations

https://doi.org/10.1038/s41591-021-01283-z

Ani Nalbandian Kartik Sehgal Aakriti Gupta Mahesh V. Madhavan

Post-COVID-19 Condition

2022 · Annual Review of Medicine · 149 citations

https://doi.org/10.1146/annurev-med-043021-030635

Ani Nalbandian Amar D. Desai Elaine Y. Wan

Sodium–Glucose Cotransporter 2 Inhibitors for Transthyretin Amyloid Cardiomyopathy: Analyses of Short-Term Efficacy and Safety

2024 · European Journal of Heart Failure · 38 citations

https://doi.org/10.1002/ejhf.3198

Frederick Lang Sergio Teruya Ariel Weinsaft Margaret Cuomo

Research topics

topics

Parathyroid Disorders and Treatments

Amyloidosis: Diagnosis, Treatment, Outcomes

COVID-19 Clinical Research Studies

Long-Term Effects of COVID-19

SARS-CoV-2 and COVID-19 Research

Chat about Author

Papers

Chat

Click to start Chat